ZVRAZEVRA THERAPEUTICS, INC.
- Market cap
- $582.55M
- as of 2026-10-23
- Latest close
- $9.81
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-11
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| McFarlane Neil F.President and CEO | Oct 12 | Oct 13 | S | 20,000 | $11.25 | Sale −$224,948 | 417,225 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10 | Oct 13 | M | 50,000 | not reported | not reported | 437,225 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10 | Oct 13 | M · derivative | 50,000 | $0.00 | $0 | 50,000 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Aug 14 | Aug 17 | S | 42,666 | $11.13 | Sale −$474,873 | 37,569 | Yes | Form 4 |
| Watton Corey Michael | Aug 10 | Aug 12 | M | 12,300 | $4.97 | $61,131 | 14,100 | No | Form 4 |
| Watton Corey Michael | Aug 10 | Aug 12 | S | 12,300 | $11.25 | Sale −$138,375 | 1,800 | No | Form 4 |
| Watton Corey Michael | Aug 10 | Aug 12 | M · derivative | 12,300 | $4.97 | $61,131 | 46,500 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 22 | Jun 23 | S | 34,557 | $12.68 | Sale −$438,183 | 80,235 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 21 | Jun 23 | M | 66,667 | not reported | not reported | 114,792 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 21 | Jun 23 | M · derivative | 66,667 | $0.00 | $0 | 66,667 | Yes | Form 4 |
| Shih Alvin | Jun 4 | Jun 18 | A · derivative | 30,000 | $11.17 | $335,100 | 30,000 | No | Form 4 |
| Anderson Thomas | Jun 4 | Jun 18 | A · derivative | 30,000 | $11.17 | $335,100 | 30,000 | No | Form 4 |
| Calder Douglas W | Jun 4 | Jun 18 | A · derivative | 30,000 | $11.17 | $335,100 | 30,000 | No | Form 4 |
| Watton Corey Michael | Jun 4 | Jun 18 | A · derivative | 30,000 | $11.17 | $335,100 | 30,000 | No | Form 4 |
| Secor Alicia | Jun 4 | Jun 18 | A · derivative | 30,000 | $11.17 | $335,100 | 30,000 | No | Form 4 |
| Favorito Tamara A | Jun 4 | Jun 18 | A · derivative | 30,000 | $11.17 | $335,100 | 30,000 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | May 28 | May 29 | A · derivative | 40,000 | $11.40 | $456,000 | 40,000 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | May 28 | May 29 | A · derivative | 20,000 | $0.00 | $0 | 20,000 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | May 11 | May 13 | S | 1,794 | $11.30 | Sale −$20,272 | 48,125 | Yes | Form 4 |
| Bode John B | Mar 24 | Mar 26 | M | 39,200 | $4.97 | $194,824 | 84,200 | No | Form 4 |
| Bode John B | Mar 24 | Mar 26 | M | 39,200 | $4.89 | $191,688 | 123,400 | No | Form 4 |
| Bode John B | Mar 24 | Mar 26 | M · derivative | 39,200 | $4.97 | $194,824 | 19,600 | No | Form 4 |
| Bode John B | Mar 24 | Mar 26 | M · derivative | 39,200 | $4.89 | $191,688 | not reported | No | Form 4 |
| Renz Justin ACFO | Mar 18 | Mar 19 | A · derivative | 300,000 | $9.55 | $2,865,000 | 300,000 | No | Form 4 |
| McFarlane Neil F.President and CEO | Feb 9 | Feb 10 | S | 14,625 | $8.56 | Sale −$125,190 | 387,225 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Feb 7 | Feb 10 | M | 37,500 | not reported | not reported | 401,850 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Feb 7 | Feb 10 | M · derivative | 37,500 | $0.00 | $0 | 75,000 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Feb 3 | Feb 4 | S | 3,000 | $9.18 | Sale −$27,540 | 29,590 | Yes | Form 4 |
| Schafer JoshuaCCO | Feb 3 | Feb 4 | S | 10,500 | $9.19 | Sale −$96,495 | 62,278 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Feb 2 | Feb 2 | S | 91,000 | $9.38 | Sale −$853,580 | 364,350 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Jan 31 | Feb 2 | M | 233,334 | not reported | not reported | 455,350 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Jan 31 | Feb 2 | M · derivative | 233,334 | $0.00 | $0 | 233,333 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 31 | Feb 2 | M | 11,666 | not reported | not reported | 32,590 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 31 | Feb 2 | M · derivative | 11,666 | $0.00 | $0 | 11,668 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 31 | Feb 2 | M | 35,334 | not reported | not reported | 72,778 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 31 | Feb 2 | M · derivative | 35,334 | $0.00 | $0 | 35,333 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 30 | Feb 2 | M | 6,333 | not reported | not reported | 22,674 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 30 | Feb 2 | S | 1,750 | $8.82 | Sale −$15,435 | 20,924 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 30 | Feb 2 | M · derivative | 6,333 | $0.00 | $0 | 12,667 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 30 | Feb 2 | M | 11,333 | not reported | not reported | 53,999 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 30 | Feb 2 | S | 4,080 | $8.83 | Sale −$36,026 | 49,919 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 30 | Feb 2 | M · derivative | 11,333 | $0.00 | $0 | 22,667 | Yes | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 30 | Feb 2 | M | 11,333 | not reported | not reported | 14,256 | Yes | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 30 | Feb 2 | S | 4,533 | $8.83 | Sale −$40,026 | 9,723 | Yes | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 30 | Feb 2 | M · derivative | 11,333 | $0.00 | $0 | 22,667 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 30 | Feb 2 | M | 11,333 | not reported | not reported | 40,819 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 30 | Feb 2 | S | 3,375 | $8.83 | Sale −$29,801 | 37,444 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 30 | Feb 2 | M · derivative | 11,333 | $0.00 | $0 | 22,667 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Jan 29 | Feb 2 | A · derivative | 125,000 | $0.00 | $0 | 125,000 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Jan 29 | Feb 2 | A · derivative | 250,000 | $8.86 | $2,215,000 | 250,000 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 29 | Feb 2 | A · derivative | 37,500 | $0.00 | $0 | 37,500 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 29 | Feb 2 | A · derivative | 75,000 | $8.86 | $664,500 | 75,000 | Yes | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 29 | Feb 2 | A · derivative | 37,500 | $0.00 | $0 | 37,500 | Yes | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 29 | Feb 2 | A · derivative | 75,000 | $8.86 | $664,500 | 75,000 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 29 | Feb 2 | A · derivative | 37,500 | $0.00 | $0 | 37,500 | Yes | Form 4 |
| Schafer JoshuaCCO | Jan 29 | Feb 2 | A · derivative | 75,000 | $8.86 | $664,500 | 75,000 | Yes | Form 4 |
| Clifton R. LaDuane | Dec 31, 2025 | Jan 7 | M | 140,667 | $0.00 | $0 | 192,028 | No | Form 4 |
| Clifton R. LaDuane | Dec 31, 2025 | Jan 7 | F | 48,513 | $8.96 | $434,676 | 143,515 | No | Form 4 |
| Clifton R. LaDuane | Dec 31, 2025 | Jan 7 | M · derivative | 86,667 | $0.00 | $0 | not reported | No | Form 4 |
| Clifton R. LaDuane | Dec 31, 2025 | Jan 7 | M · derivative | 34,000 | $0.00 | $0 | not reported | No | Form 4 |
| Clifton R. LaDuane | Dec 31, 2025 | Jan 7 | M · derivative | 20,000 | $0.00 | $0 | not reported | No | Form 4 |
| Secor Alicia | Dec 2, 2025 | Dec 9, 2025 | A · derivative | 45,000 | $8.17 | $367,650 | 45,000 | No | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10, 2025 | Oct 10, 2025 | M | 50,000 | not reported | not reported | 241,516 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10, 2025 | Oct 10, 2025 | S | 19,500 | $10.82 | Sale −$210,990 | 222,016 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10, 2025 | Oct 10, 2025 | M · derivative | 50,000 | $0.00 | $0 | 100,000 | Yes | Form 4 |
| Favorito Tamara A | Sep 12, 2025 | Sep 16, 2025 | P | 3,175 | $7.79 | Purchase +$24,733 | 3,894 | No | Form 4 |
| Shih Alvin | Sep 12, 2025 | Sep 15, 2025 | P | 20,000 | $7.89 | Purchase +$157,800 | 20,000 | No | Form 4 |
| Bode John B | Aug 19, 2025 | Aug 20, 2025 | P | 5,000 | $9.17 | Purchase +$45,850 | 45,000 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 26, 2025 | Jun 30, 2025 | S | 24,000 | $9.21 | Sale −$221,040 | 42,666 | Yes | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 21, 2025 | Jun 24, 2025 | M | 66,666 | not reported | not reported | 66,666 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 21, 2025 | Jun 24, 2025 | M · derivative | 66,666 | $0.00 | $0 | 133,334 | No | Form 4 |
| Anderson Thomas | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Bode John B | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Watton Corey Michael | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Favorito Tamara A | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Calder Douglas W | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Dixon Wendy L | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Shih Alvin | May 29, 2025 | May 30, 2025 | A · derivative | 30,000 | $8.62 | $258,600 | 30,000 | No | Form 4 |
| Watton Corey Michael | Mar 28, 2025 | Mar 31, 2025 | P | 300 | $7.84 | Purchase +$2,352 | 1,800 | No | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 30, 2025 | Mar 27, 2025 | A · derivative | 68,000 | $8.02 | $545,360 | 68,000 | No | Form 4 |
| Quartel Adrian WChief Medical Officer | Jan 30, 2025 | Mar 27, 2025 | A · derivative | 34,000 | $0.00 | $0 | 34,000 | No | Form 4 |
| Bode John B | Mar 19, 2025 | Mar 21, 2025 | P | 10,000 | $7.96 | Purchase +$79,600 | 40,000 | No | Form 4 |
| McFarlane Neil F.President and CEO | Feb 14, 2025 | Feb 14, 2025 | S | 30,544 | $8.05 | Sale −$245,879 | 191,516 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Feb 13, 2025 | Feb 14, 2025 | S | 61,273 | $7.86 | Sale −$481,606 | 222,060 | Yes | Form 4 |
| Clifton R. LaDuaneCFO & Treasurer | Feb 13, 2025 | Feb 14, 2025 | S | 11,000 | $7.86 | Sale −$86,460 | 51,361 | Yes | Form 4 |
| Schafer JoshuaCCO & EVP, Bus. Development | Feb 13, 2025 | Feb 14, 2025 | S | 10,500 | $7.86 | Sale −$82,530 | 29,486 | Yes | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Feb 13, 2025 | Feb 14, 2025 | S | 3,000 | $7.86 | Sale −$23,580 | 16,341 | Yes | Form 4 |
| McFarlane Neil F.President and CEO | Feb 7, 2025 | Feb 10, 2025 | A · derivative | 225,000 | $7.77 | $1,748,250 | 225,000 | No | Form 4 |
| McFarlane Neil F.President and CEO | Feb 7, 2025 | Feb 10, 2025 | A · derivative | 112,500 | $0.00 | $0 | 112,500 | No | Form 4 |
| McFarlane Neil F.President and CEO | Jan 31, 2025 | Feb 3, 2025 | M | 233,333 | not reported | not reported | 283,333 | No | Form 4 |
| McFarlane Neil F.President and CEO | Jan 31, 2025 | Feb 3, 2025 | M · derivative | 233,333 | $0.00 | $0 | 466,667 | No | Form 4 |
| Clifton R. LaDuaneCFO & Treasurer | Jan 31, 2025 | Feb 3, 2025 | M | 43,333 | not reported | not reported | 62,361 | No | Form 4 |
| Clifton R. LaDuaneCFO & Treasurer | Jan 31, 2025 | Feb 3, 2025 | M · derivative | 43,333 | $0.00 | $0 | 86,667 | No | Form 4 |
| Schafer JoshuaCCO & EVP, Bus. Development | Jan 31, 2025 | Feb 3, 2025 | M | 35,333 | not reported | not reported | 39,986 | No | Form 4 |
| Schafer JoshuaCCO & EVP, Bus. Development | Jan 31, 2025 | Feb 3, 2025 | M · derivative | 35,333 | $0.00 | $0 | 70,667 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 31, 2025 | Feb 3, 2025 | M | 11,666 | not reported | not reported | 19,341 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 31, 2025 | Feb 3, 2025 | M · derivative | 11,666 | $0.00 | $0 | 23,334 | No | Form 4 |
| Clifton R. LaDuaneCFO & Treasurer | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 68,000 | $8.02 | $545,360 | 68,000 | No | Form 4 |
| Clifton R. LaDuaneCFO & Treasurer | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 34,000 | $0.00 | $0 | 34,000 | No | Form 4 |
| Schafer JoshuaCCO & EVP, Bus. Development | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 68,000 | $8.02 | $545,360 | 68,000 | No | Form 4 |
| Schafer JoshuaCCO & EVP, Bus. Development | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 34,000 | $0.00 | $0 | 34,000 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 68,000 | $8.02 | $545,360 | 68,000 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 34,000 | $0.00 | $0 | 34,000 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 38,000 | $8.02 | $304,760 | 38,000 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Finance & Corp Controller | Jan 30, 2025 | Feb 3, 2025 | A · derivative | 19,000 | $0.00 | $0 | 19,000 | No | Form 4 |
| Watton Corey Michael | Oct 11, 2024 | Oct 16, 2024 | P | 500 | $7.92 | Purchase +$3,960 | 1,500 | No | Form 4 |
| Clifton R. LaDuaneCFO & Treasurer | Jul 17, 2024 | Jul 17, 2024 | P | 2,000 | $6.77 | Purchase +$13,540 | 18,469 | No | Form 4 |
| Anderson Thomas | Jul 16, 2024 | Jul 16, 2024 | P | 10,000 | $6.81 | Purchase +$68,100 | 20,000 | No | Form 4 |
| Bode John B | Jul 12, 2024 | Jul 15, 2024 | P | 10,000 | $5.87 | Purchase +$58,700 | 30,000 | No | Form 4 |
| Thompson RahsaanChief Legal & Compliance | Jun 21, 2024 | Jun 25, 2024 | A · derivative | 200,000 | $0.00 | $0 | 200,000 | No | Form 4 |
| Anderson Thomas | May 13, 2024 | May 15, 2024 | A · derivative | 39,200 | $4.89 | $191,688 | 39,200 | No | Form 4 |
| Shih Alvin | May 13, 2024 | May 15, 2024 | A · derivative | 39,200 | $4.89 | $191,688 | 39,200 | No | Form 4 |
| Watton Corey Michael | May 13, 2024 | May 15, 2024 | A · derivative | 39,200 | $4.89 | $191,688 | 39,200 | No | Form 4 |
| Calder Douglas W | May 13, 2024 | May 15, 2024 | A · derivative | 39,200 | $4.89 | $191,688 | 39,200 | No | Form 4 |
| Favorito Tamara A | May 13, 2024 | May 15, 2024 | A · derivative | 49,200 | $4.89 | $240,588 | 49,200 | No | Form 4 |
| Dixon Wendy L | May 13, 2024 | May 15, 2024 | A · derivative | 39,200 | $4.89 | $191,688 | 39,200 | No | Form 4 |
| Bode John B | May 13, 2024 | May 15, 2024 | A · derivative | 39,200 | $4.89 | $191,688 | 39,200 | No | Form 4 |
| McFarlane Neil F.President and CEO | Jan 31, 2024 | Feb 2, 2024 | A · derivative | 700,000 | $0.00 | $0 | 700,000 | No | Form 4 |
| Clifton R. LaDuaneCFO, Secretary & Treasurer | Jan 31, 2024 | Feb 2, 2024 | A · derivative | 130,000 | $0.00 | $0 | 130,000 | No | Form 4 |
| Guenther SvenChief Scientific Officer | Jan 31, 2024 | Feb 2, 2024 | A · derivative | 79,000 | $0.00 | $0 | 79,000 | No | Form 4 |
| Mickle Christal M MChief Development Officer | Jan 31, 2024 | Feb 2, 2024 | A · derivative | 77,000 | $0.00 | $0 | 77,000 | No | Form 4 |
| Sangiovanni Timothy J.SVP, Corporate Controller | Jan 31, 2024 | Feb 2, 2024 | A · derivative | 35,000 | $0.00 | $0 | 35,000 | No | Form 4 |
| Schafer JoshuaCCO & EVP, Bus. Development | Jan 31, 2024 | Feb 2, 2024 | A · derivative | 106,000 | $0.00 | $0 | 106,000 | No | Form 4 |
| Shih Alvin | Jan 20, 2024 | Feb 2, 2024 | A · derivative | 58,800 | $5.72 | $336,336 | 58,800 | No | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10, 2023 | Oct 11, 2023 | A · derivative | 600,000 | $4.75 | $2,850,000 | 600,000 | No | Form 4 |
| McFarlane Neil F.President and CEO | Oct 10, 2023 | Oct 11, 2023 | A · derivative | 200,000 | $0.00 | $0 | 200,000 | No | Form 4 |